Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

Search/

Search/

Loading…

Matthew Gline: insider trades filed with the SEC | OQRO

Home
Insider trades
Matthew Gline

Reporting person on SEC Form 4

Matthew Gline

Matthew Gline is CEO at Roivant Sciences. OQRO lists 19 transactions filed with the SEC under this name, the latest on Oct 3, 2026, each linked to the official Form 4.

CEO

Disclosures on record

19

Companies involved

1

Disclosure history

Roivant SciencesROIV
19 disclosures · Dec 2025 – Oct 2026 · 4 sold
- Sep 30, 202676Kdisclosed Oct 3
  Details Official record
- Jun 30, 202676Kdisclosed Jul 3
  Details Official record
- Apr 16, 2026Sold~$8.45Mdisclosed Apr 21
  Details Official record

Companies

Roivant Sciences ROIV19 events

Mar 30, 20262.18Mdisclosed Apr 2

Details Official record

Mar 30, 202697Kdisclosed Apr 2

Details Official record

Mar 30, 202654Kdisclosed Apr 2

Details Official record

Mar 31, 2026305Kdisclosed Apr 2

Details Official record

Dec 15, 2025Sold~$20.5Mdisclosed Dec 18

Details Official record

Dec 15, 2025Sold~$12.3Mdisclosed Dec 18

Details Official record

Dec 15, 2025Sold~$4.99Mdisclosed Dec 18

Details Official record

Dec 15, 20251.36Mdisclosed Dec 18

Details Official record

Dec 15, 2025234Kdisclosed Dec 18

Details Official record

Dec 15, 2025234Kdisclosed Dec 18

Details Official record

Dec 15, 20251.36Mdisclosed Dec 18

Details Official record

Dec 15, 20252.27Mdisclosed Dec 18

Details Official record

Dec 15, 20252.27Mdisclosed Dec 18

Details Official record

Dec 15, 2025798Kdisclosed Dec 18

Details Official record

Dec 15, 20251.33Mdisclosed Dec 18

Details Official record

Dec 15, 20253,739disclosed Dec 18

Details Official record

All activity in Roivant Sciences